atypical antipsychotics increasing mortality in elderly patients with dementia

See updated information from the FDA

You'll see new boxed warnings about atypical antipsychotics increasing mortality in elderly patients with dementia.

This creates a real dilemma.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote